BML, Inc. provides contract clinical testing and related services in Japan. The company offers a range of laboratory testing, such as biochemical and hematologic examination; laboratory test, including tumor markers, infectious diseases, hormones, cellular immunity, genetics, bacteriological tests, and other test; specialized testing in oncology, infectious diseases, diabetes, hypertension, allergies, genetics, and more areas, as well as develops Frontier and Symphony automation systems, which automate pre-testing from specimen sorting to dispensing. It also provides contract clinical testing, including endocrine, plasma protein, biochemical, viral, immunoserological, hematological, cellular immunity, bacteriological, and histopathological, pathological, and cytological tests; specimen receiving service; and medical information system services, which include electronic medical charts for clinics without beds. In addition, the company is involved in manufacturing and supply services for medical equipment and supplies; real estate leasing and insurance agency business; providing food hygiene inspection and food consulting services; and dispensing pharmacy services. The company was incorporated in 1955 and is headquartered in Tokyo, Japan.
Metrics to compare | 4694 | Sector Sector - Average of metrics from a broad group of related Healthcare sector companies | Relationship Relationship4694PeersSector | |
|---|---|---|---|---|
P/E Ratio | 21.3x | 16.2x | −0.7x | |
PEG Ratio | 2.70 | 0.41 | 0.00 | |
Price/Book | 1.1x | 1.6x | 2.6x | |
Price / LTM Sales | 0.9x | 0.6x | 3.4x | |
Upside (Analyst Target) | 14.9% | 5.7% | 39.1% | |
Fair Value Upside | Unlock | 26.9% | 5.5% | Unlock |